• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriers

tetano

Editor, Senior Moderator
Vaccine. 2018 Mar 16. pii: S0264-410X(18)30343-8. doi: 10.1016/j.vaccine.2018.03.007. [Epub ahead of print]
[h=1]Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriers.[/h] Alfelali M[SUP]1[/SUP], Barasheed O[SUP]2[/SUP], Badahdah AM[SUP]3[/SUP], Bokhary H[SUP]4[/SUP], Azeem MI[SUP]5[/SUP], Habeebullah T[SUP]6[/SUP], Bakarman M[SUP]7[/SUP], Asghar A[SUP]6[/SUP], Booy R[SUP]8[/SUP], Rashid H[SUP]8[/SUP]; Hajj Research Team.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Hajj is the world's largest annual mass gathering that attracts two to three million Muslims from around the globe to a religious assemblage in Makkah, Saudi Arabia. The risk of acquisition and transmission of influenza among Hajj pilgrims is high. Therefore, influenza vaccination is recommended, and was monitored frequently among pilgrims from different countries. However, the vaccination uptake among Saudi pilgrims has not been assessed in recent years.
[h=4]OBJECTIVE:[/h] This analysis aims to evaluate influenza vaccine uptake among Saudi Hajj pilgrims, and identify the key barriers to vaccination.
[h=4]METHOD:[/h] Data on influenza vaccination were obtained from Saudi pilgrims who took part in a large trial during the Hajj of 2013, 2014 and 2015. Pilgrims were met and recruited in Mina, Makkah during the peak period of Hajj and were asked to complete a baseline questionnaire that recorded their influenza vaccination history, including reason(s) for non-receipt of vaccine.
[h=4]RESULTS:[/h] A total of 6974 Saudi pilgrims aged between 18 and 95 (median 34) years were recruited; male to female ratio was 1:1.2. Of the total, 90.8% declared their influenza vaccination history, 51.3% of them reported receiving influenza vaccine before travel to Hajj. The vaccination rates for the years 2013, 2014 and 2015 were 21.4%, 48.2% and 58.1%, respectively (P < 0.001). Of 1,269 pilgrims who were at higher risk of severe disease, 54.5% received the vaccine. Lack of awareness (47.5%), reliance on natural immunity (15.8%) and being busy (15.5%) were the main reasons for non-receipt.
[h=4]CONCLUSION:[/h] These data from a convenience sample indicate that influenza vaccine uptake among Saudi Hajj pilgrims is increasing over years but still needs further improvement. Lack of awareness and misperceptions are the main barriers. Education of Saudi pilgrims and health professionals is required to raise awareness about influenza vaccination. Further studies are needed to understand pilgrims' misperceptions.
Copyright ? 2018 Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Hajj; Influenza; Influenza vaccine; Saudi Arabia; Vaccine; Vaccine uptake

PMID: 29555221 DOI: 10.1016/j.vaccine.2018.03.007
 
Back
Top Bottom